The University of Southampton
University of Southampton Institutional Repository

Increased plasma tumour necrosis factor alpha in severe alcoholic hepatitis

Increased plasma tumour necrosis factor alpha in severe alcoholic hepatitis
Increased plasma tumour necrosis factor alpha in severe alcoholic hepatitis
Study Objective: To determine whether elevated tumor necrosis factor levels contribute to the clinical manifestations and complications of severe acute alcoholic hepatitis and to evaluate the relation between tumor necrosis factor and plasma levels of endotoxin and interleukin-1ß

Design: Prospective, controlled study.

Setting: The liver unit of a university teaching hospital.

Patients: We studied 21 patients with acute severe alcoholic hepatitis. There were four control groups: patients with inactive alcoholic cirrhosis, alcoholic persons without liver disease, patients with impaired renal function, and normal subjects.

Measurements and Main Results: With one exception, patients with alcoholic hepatitis had higher tumor necrosis factor levels (mean, 26.3 ng/L; 95% CI, 21.7 to 30.9) than normal subjects (6.4 ng/L; CI, 5.4 to 7.4). Patients who subsequently died had a higher tumor necrosis factor level (34.7 ng/L; CI, 27.8 to 41.6) than survivors (16.6 ng/L; CI, 14.0 to 19.2). In patients with alcoholic hepatitis, tumor necrosis factor levels correlated positively with serum bilirubin (r = 0.74; P = 0.0009) and serum creatinine (r = 0.81; P = 0.0003). Patients with alcoholic hepatitis had higher tumor necrosis factor levels than patients with inactive alcoholic cirrhosis (11.1 ng/L; CI, 8.9 to 13.3) and severely alcoholic persons without liver disease (6.4 ng/L; CI, 5.0 to 7.8). Patients with abnormal renal function had lower tumor necrosis factor levels (14.1 ng/L; CI, 5.4 to 22.8) than patients with alcoholic hepatitis. Serial samples obtained during a 1-week period from patients with alcoholic hepatitis showed no significant change in tumor necrosis factor when patients who died were compared with survivors. No correlation was found between tumor necrosis factor and plasma endotoxin. Levels of interleukin-1ß did not exceed 20 ng/L.

Conclusions: Elevations in tumor necrosis factor in alcoholic hepatitis are most marked in severe cases, suggesting that tumor necrosis factor plays a role in the pathogenesis.

0003-4819
917-920
Bird, George L.A.
5ac640af-59ff-49b3-b24c-18f0db019c38
Sheron, Nick
cbf852e3-cfaa-43b2-ab99-a954d96069f1
Goka, John
fe553a8a-2f4d-4390-b0a2-6164f2b13860
Alexander, Graeme J.
3373aaa7-0249-4edd-b88f-a63677f32bba
Williams, Roger S.
30302116-9f5e-4835-9f29-a53cb65f665c
Bird, George L.A.
5ac640af-59ff-49b3-b24c-18f0db019c38
Sheron, Nick
cbf852e3-cfaa-43b2-ab99-a954d96069f1
Goka, John
fe553a8a-2f4d-4390-b0a2-6164f2b13860
Alexander, Graeme J.
3373aaa7-0249-4edd-b88f-a63677f32bba
Williams, Roger S.
30302116-9f5e-4835-9f29-a53cb65f665c

Bird, George L.A., Sheron, Nick, Goka, John, Alexander, Graeme J. and Williams, Roger S. (1990) Increased plasma tumour necrosis factor alpha in severe alcoholic hepatitis. Annals of Internal Medicine, 112 (12), 917-920. (PMID:2339855)

Record type: Article

Abstract

Study Objective: To determine whether elevated tumor necrosis factor levels contribute to the clinical manifestations and complications of severe acute alcoholic hepatitis and to evaluate the relation between tumor necrosis factor and plasma levels of endotoxin and interleukin-1ß

Design: Prospective, controlled study.

Setting: The liver unit of a university teaching hospital.

Patients: We studied 21 patients with acute severe alcoholic hepatitis. There were four control groups: patients with inactive alcoholic cirrhosis, alcoholic persons without liver disease, patients with impaired renal function, and normal subjects.

Measurements and Main Results: With one exception, patients with alcoholic hepatitis had higher tumor necrosis factor levels (mean, 26.3 ng/L; 95% CI, 21.7 to 30.9) than normal subjects (6.4 ng/L; CI, 5.4 to 7.4). Patients who subsequently died had a higher tumor necrosis factor level (34.7 ng/L; CI, 27.8 to 41.6) than survivors (16.6 ng/L; CI, 14.0 to 19.2). In patients with alcoholic hepatitis, tumor necrosis factor levels correlated positively with serum bilirubin (r = 0.74; P = 0.0009) and serum creatinine (r = 0.81; P = 0.0003). Patients with alcoholic hepatitis had higher tumor necrosis factor levels than patients with inactive alcoholic cirrhosis (11.1 ng/L; CI, 8.9 to 13.3) and severely alcoholic persons without liver disease (6.4 ng/L; CI, 5.0 to 7.8). Patients with abnormal renal function had lower tumor necrosis factor levels (14.1 ng/L; CI, 5.4 to 22.8) than patients with alcoholic hepatitis. Serial samples obtained during a 1-week period from patients with alcoholic hepatitis showed no significant change in tumor necrosis factor when patients who died were compared with survivors. No correlation was found between tumor necrosis factor and plasma endotoxin. Levels of interleukin-1ß did not exceed 20 ng/L.

Conclusions: Elevations in tumor necrosis factor in alcoholic hepatitis are most marked in severe cases, suggesting that tumor necrosis factor plays a role in the pathogenesis.

This record has no associated files available for download.

More information

Published date: 15 June 1990

Identifiers

Local EPrints ID: 172295
URI: http://eprints.soton.ac.uk/id/eprint/172295
ISSN: 0003-4819
PURE UUID: a761b4df-8fb5-4fdf-818a-80415340997f
ORCID for Nick Sheron: ORCID iD orcid.org/0000-0001-5232-8292

Catalogue record

Date deposited: 25 Jan 2011 12:10
Last modified: 22 Jul 2022 17:34

Export record

Contributors

Author: George L.A. Bird
Author: Nick Sheron ORCID iD
Author: John Goka
Author: Graeme J. Alexander
Author: Roger S. Williams

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×